Assertio Therapeutics, Inc. Recorded Big Gain
Thu, Dec 12, 2019 at 05:30 PM
Assertio Therapeutics, Inc. (ASRT:NASDAQ) jumped higher at $1.23, representing a gain of 56.6%. On Wed 11 Dec 19, ASRT:NASDAQ hit a New 2-Week High of $0.79. The stock got featured on our News Catalysts scanner on Tue 10 Dec 19 at 05:28 PM in the 'INVESTOR UPDATE' category. From Wed 20 Nov 19, the stock recorded 42.86% Up Days and 26.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Assertio Therapeutics, Inc. (ASRT:NASDAQ)
Depomed Inc is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.
Top 10 Gainers:
- Assertio Therapeutics, Inc. (ASRT:NASDAQ), 56.65%
- Amneal Pharmaceuticals, Inc. (AMRX:NYSE), 44.83%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 44.67%
- Pacific Coast Oil Trust (ROYT:NYSE), 38.26%
- Assembly Biosciences, Inc. (ASMB:NASDAQ), 34.44%
- Ferroglobe PLC (GSM:NASDAQ), 32.6%
- LSC Communications, Inc. (LKSD:NYSE), 28.19%
- CTI BioPharma Corp. (CTIC:NASDAQ), 26.45%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 25.54%
- Top Ships Inc. (TOPS:NASDAQ), 24.48%